Gluconeogenic signals regulate hepcidin gene expression via a CRBN-KLF15 axis
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Hepcidin (HAMP) is synthesized in the liver. It is a key ironregulatory hormone that controls systemic iron homeostasis. Cereblon (CRBN) and Kruppel-like factor 15 (KLF15) are known to regulate diverse physiological functions. In this study, we investigated the role of CRBN on hepatic hepcidin gene expression and production under gluconeogenic stimuli. Fasted mice as well as forskolin (FSK)- and glucagon (GLU)-treated mice had reduced serum iron levels but increased expression levels of hepatic Crbn and Klf15 and hepcidin secretion. MicroRNA (miRNA) expression analysis of fasted and Ad-Crbninfected mice revealed significant reduction of microRNA-639 (miR-639). Hepatic overexpression of Crbn elevated hepcidin expression and production along with Klf15 gene expression, whereas knockdown of Crbn and Klf15 markedly decreased FSK- and fasting-mediated induction of hepcidin gene expression and its biosynthesis in mouse livers and primary hepatocytes. Moreover, expression of KLF15 significantly increased the activity of hepcidin reporter gene. It was exclusively dependent on the KLF15-binding site identified within the hepcidin gene promoter. Overall, this study demonstrates that CRBN and KLF15 are novel mediators of gluconeogenic signal-induced hepcidin gene expression and production. Thus, CRBN and KLF15 might be novel potential therapeutic targets to intervene metabolic dysfunction.
Abstract
Hepcidin (HAMP) is synthesized in the liver. It is a key ironregulatory hormone that controls systemic iron homeostasis. Cereblon (CRBN) and Kruppel-like factor 15 (KLF15) are known to regulate diverse physiological functions. In this study, we investigated the role of CRBN on hepatic hepcidin gene expression and production under gluconeogenic stimuli. Fasted mice as well as forskolin (FSK)- and glucagon (GLU)-treated mice had reduced serum iron levels but increased expression levels of hepatic Crbn and Klf15 and hepcidin secretion. MicroRNA (miRNA) expression analysis of fasted and Ad-Crbninfected mice revealed significant reduction of microRNA-639 (miR-639). Hepatic overexpression of Crbn elevated hepcidin expression and production along with Klf15 gene expression, whereas knockdown of Crbn and Klf15 markedly decreased FSK- and fasting-mediated induction of hepcidin gene expression and its biosynthesis in mouse livers and primary hepatocytes. Moreover, expression of KLF15 significantly increased the activity of hepcidin reporter gene. It was exclusively dependent on the KLF15-binding site identified within the hepcidin gene promoter. Overall, this study demonstrates that CRBN and KLF15 are novel mediators of gluconeogenic signal-induced hepcidin gene expression and production. Thus, CRBN and KLF15 might be novel potential therapeutic targets to intervene metabolic dysfunction.
참고문헌 (31)
- Anderson ER, "Iron homeostasis in the liver", Compr Physiol, 3, pp.315~330 (2013)
- Zumerle S, "Targeted disruption of hepcidin in the liver recapitulates the hemochromatotic phenotype", Blood, 123, pp.3646~3650 (2014)
- Lesbordes-Brion JC, "Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis", Blood, 108, pp.1402~1405 (2006)
- Deschemin JC, "Pulmonary iron homeostasis in hepcidin knockout mice", Front Physiol, 8, pp.804~ (2017)
- Viatte L, "Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice", Blood, 105, pp.4861~4864 (2005)
- Nicolas G, "Severe iron deficiency anemia in transgenic mice expressing liver hepcidin", Proc Natl Acad Sci U S A, 99, pp.4596~4601 (2002)
- Ganz T, "Hepcidin and iron homeostasis", Biochim Biophys Acta, 1823, pp.1434~1443 (2012)
- Lee SE, "B-cell translocation gene 2 promotes hepatic hepcidin production via induction of Yin Yang 1", Biochem Biophys Res Commun, 460, pp.996~1001 (2015)
- Shi Q, "Cereblon : a protein crucial to the multiple functions of immunomodulatory drugs as well as cell metabolism and disease generation", J Immunol Res, 2017, pp.9130608~ (2017)
- Chang XB, "What is the functional role of the thalidomide binding protein cereblon?", Int J Biochem Mol Biol, 2, pp.287~294 (2011)
- Kim HK, "Cereblon in health and disease", Pflugers Arch, 468, pp.1299~1309 (2016)
- Lee KM, "Functional effects of a pathogenic mutation in Cereblon(CRBN)on the regulation of protein synthesis via the AMPK-mTOR cascade", J Biol Chem, 289, pp.23343~23352 (2014)
- Lee KM, "Disruption of the cereblon gene enhances hepatic AMPK activity and prevents high-fat diet-induced obesity and insulin resistance in mice", Diabetes, 62, pp.855~1864 (2013)
- Lee KM, "Functional modulation of AMP-activated protein kinase by cereblon", Biochim Biophys Acta, 1813, pp.448~455 (2011)
- Foretz M, "Regulation of hepatic metabolism by AMPK", J Hepatol, 54, pp.827~829 (2011)
- Kim YD, "Inhibition of cereblon by fenofibrate ameliorates alcoholic liver disease by enhancing AMPK", Biochim Biophys Acta, 1852, pp.2662~2670 (2015)
- Kim YD, "B-cell translocation gene 2 enhances fibroblast growth factor 21production by inducing Kruppel-like factor 15", Sci Rep, 9, pp.3730~ (2019)
- McConnell BB, "Mammalian Kruppellike factors in health and diseases", Physiol Rev, 90, pp.1337~1381 (2010)
- Teshigawara K, "Role of Kruppel-like factor 15 in PEPCK gene expression in the liver", Biochem Biophys Res Commun, 327, pp.920~926 (2005)
- Pearson R, "Kruppel-like transcription factors : a functional family", Int J Biochem Cell Biol, 40, pp.1996~2001 (2008)
- Vecchi C, "Gluconeogenic signals regulate iron homeostasis via hepcidin in mice", Gastroenterology, 146, pp.1060~1069 (2014)
- Xu Q, "Expression of the cereblon binding protein argonaute 2 plays an important role for multiple myeloma cell growth and survival", BMC Cancer, 16, pp.297~ (2016)
- Zhang Y, "Adenine alleviates iron overload by cAMP", PKA mediated hepatic hepcidin in mice, 2018, pp.233, 7268~7278
- Aigner E, "Glucose acts as a regulator of serum iron by increasing serum hepcidin concentrations", J Nutr Biochem, 24, pp.112~117 (2013)
- Ruchala P, "The pathophysiology and pharmacology of hepcidin", Trends Pharmacol Sci, 35, pp.155~161 (2014)
- Rishi G, "Hepcidin : regulation of the master iron regulator", Biosci Rep, 35, pp.e00192~ (2015)
- Fung E, "Manipulation of the hepcidin pathway for therapeutic purposes", Haematologica, 98, pp.1667~1676 (2013)
- Ganz T, "Hepcidin and disorders of iron metabolism", Annu Rev Med, 62, pp.347~360 (2011)
- Wei C, "Effects of psychological stress on serum iron and erythropoiesis", Int J Hematol, 88, pp.52~56 (2008)
- Navas FJ, "Iron distribution in different tissues in rats following exercise", Biol Trace Elem Res, 73, pp.259~268 (2000)
- Sangkhae V, "Regulation of the iron homeostatic hormone hepcidin", Adv Nutr, 8, pp.126~136 (2017)